156 related articles for article (PubMed ID: 9288609)
1. Aberrant dipeptidyl peptidase IV (DPP IV/CD26) expression in human hepatocellular carcinoma.
Stecca BA; Nardo B; Chieco P; Mazziotti A; Bolondi L; Cavallari A
J Hepatol; 1997 Aug; 27(2):337-45. PubMed ID: 9288609
[TBL] [Abstract][Full Text] [Related]
2. Altered zonal expression of the CD26 antigen (dipeptidyl peptidase IV) in human cirrhotic liver.
Matsumoto Y; Bishop GA; McCaughan GW
Hepatology; 1992 Jun; 15(6):1048-53. PubMed ID: 1350563
[TBL] [Abstract][Full Text] [Related]
3. Enzymatic cytochemistry, DNA ploidy and AgNOR quantitation in hepatocellular nodules of uncertain malignant potential in liver cirrhosis.
Bolondi L; Gramantieri L; Chieco P; Melchiorri C; Treré D; Stecca B; Derenzini M; Barbara L
Dig Dis Sci; 1996 Apr; 41(4):800-8. PubMed ID: 8674404
[TBL] [Abstract][Full Text] [Related]
4. Identification of the bile canalicular cell surface molecule GP110 as the ectopeptidase dipeptidyl peptidase IV: an analysis by tissue distribution, purification and N-terminal amino acid sequence.
McCaughan GW; Wickson JE; Creswick PF; Gorrell MD
Hepatology; 1990 Apr; 11(4):534-44. PubMed ID: 1970322
[TBL] [Abstract][Full Text] [Related]
5. Dipeptidylpeptidase--IV, a key enzyme for the degradation of incretins and neuropeptides: activity and expression in the liver of lean and obese rats.
Tarantola E; Bertone V; Milanesi G; Capelli E; Ferrigno A; Neri D; Vairetti M; Barni S; Freitas I
Eur J Histochem; 2012 Oct; 56(4):e41. PubMed ID: 23361237
[TBL] [Abstract][Full Text] [Related]
6. Integration of transplanted hepatocytes into host liver plates demonstrated with dipeptidyl peptidase IV-deficient rats.
Gupta S; Rajvanshi P; Lee CD
Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5860-4. PubMed ID: 7597042
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum dipeptidyl peptidase IV (CD26, EC 3.4.14.5) activity in experimental liver cirrhosis.
Lakatos PL; Firneisz G; Borcsiczky D; Zalatnai A; Selmeci L; Szalay F
Eur J Clin Invest; 2000 Sep; 30(9):793-7. PubMed ID: 10998079
[TBL] [Abstract][Full Text] [Related]
8. Multicolor cytoenzymatic evaluation of dipeptidyl peptidase IV (CD26) function in normal and neoplastic human T-lymphocyte populations.
Ruiz P; Zacharievich N; Shenkin M
Clin Diagn Lab Immunol; 1998 May; 5(3):362-8. PubMed ID: 9605992
[TBL] [Abstract][Full Text] [Related]
9. Canalicular immunostaining of neprilysin (CD10) as a diagnostic marker for hepatocellular carcinomas.
Borscheri N; Roessner A; Röcken C
Am J Surg Pathol; 2001 Oct; 25(10):1297-303. PubMed ID: 11688465
[TBL] [Abstract][Full Text] [Related]
10. Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas.
Stremenová J; Mares V; Lisá V; Hilser M; Krepela E; Vanicková Z; Syrucek M; Soula O; Sedo A
Int J Oncol; 2010 Feb; 36(2):351-8. PubMed ID: 20043068
[TBL] [Abstract][Full Text] [Related]
11. Carcinoembryonic antigen and lectin binding in the bile canalicular structures of hepatocellular carcinoma.
Machinami R; Oono Y
Virchows Arch A Pathol Anat Histopathol; 1987; 412(2):111-8. PubMed ID: 2827370
[TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl-peptidase IV-beta--further characterization and comparison to dipeptidyl-peptidase IV activity of CD26.
Blanco J; Nguyen C; Callebaut C; Jacotot E; Krust B; Mazaleyrat JP; Wakselman M; Hovanessian AG
Eur J Biochem; 1998 Sep; 256(2):369-78. PubMed ID: 9760177
[TBL] [Abstract][Full Text] [Related]
13. Dipeptidyl-peptidase IV-beta, a novel form of cell-surface-expressed protein with dipeptidyl-peptidase IV activity.
Jacotot E; Callebaut C; Blanco J; Krust B; Neubert K; Barth A; Hovanessian AG
Eur J Biochem; 1996 Jul; 239(2):248-58. PubMed ID: 8706727
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the differentiation potential of WB-F344 rat liver epithelial stem-like cells in vivo. Differentiation to hepatocytes after transplantation into dipeptidylpeptidase-IV-deficient rat liver.
Coleman WB; McCullough KD; Esch GL; Faris RA; Hixson DC; Smith GJ; Grisham JW
Am J Pathol; 1997 Aug; 151(2):353-9. PubMed ID: 9250149
[TBL] [Abstract][Full Text] [Related]
15. In vivo modulation of CD26 (dipeptidyl peptidase IV) in the mouse: effects of polyreactive and monoreactive antibodies.
Yamaguchi N; Plant C; Biancone L; Bachovchin W; McCluskey R; Andres G
Transplantation; 1996 Oct; 62(7):973-85. PubMed ID: 8878393
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis.
Levy MT; McCaughan GW; Abbott CA; Park JE; Cunningham AM; Müller E; Rettig WJ; Gorrell MD
Hepatology; 1999 Jun; 29(6):1768-78. PubMed ID: 10347120
[TBL] [Abstract][Full Text] [Related]
17. Hepatic Dipeptidyl Peptidase-4 Controls Pharmacokinetics of Vildagliptin In Vivo.
Asakura M; Fukami T; Nakajima M; Fujii H; Atsuda K; Itoh T; Fujiwara R
Drug Metab Dispos; 2017 Feb; 45(2):237-245. PubMed ID: 27895112
[TBL] [Abstract][Full Text] [Related]
18. SerpinB3 induces dipeptidyl-peptidase IV/CD26 expression and its metabolic effects in hepatocellular carcinoma.
Fasolato S; Trevellin E; Ruvoletto M; Granzotto M; Zanus G; Boscaro E; Babetto E; Terrin L; Battocchio MA; Ciscato F; Turato C; Quarta S; Cillo U; Pontisso P; Vettor R
Life Sci; 2018 May; 200():134-141. PubMed ID: 29524519
[TBL] [Abstract][Full Text] [Related]
19. Quantitative immunogold localization of dipeptidyl peptidase IV (DPP IV) in rat liver cells.
Fukui Y; Yamamoto A; Kyoden T; Kato K; Tashiro Y
Cell Struct Funct; 1990 Apr; 15(2):117-25. PubMed ID: 1972662
[TBL] [Abstract][Full Text] [Related]
20. Monitoring of dipeptidyl peptidase-IV (DPP-IV) activity in patients with mucopolysaccharidoses types I and II on enzyme replacement therapy - Results of a pilot study.
Hetmańczyk K; Bednarska-Makaruk M; Kierus K; Murawska-Izdebska S; Piekutowska-Abramczuk D; Pilch B; Tylki-Szymańska A; Ługowska A
Clin Biochem; 2016 Apr; 49(6):458-462. PubMed ID: 26592960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
